Overcoming multidrug resistance: antimicrobial peptides as a next-generation therapeutic strategy
Frontiers in Cellular and Infection Microbiology · 19.02.2026 · 16
DOI: 10.3389/fcimb.2026.1745427 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.02.2026. Verfasst von Shiqi Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn and Plastic Surgery, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong,…. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Bacteria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amidst the escalating global threat of antibiotic resistance, there is an urgent need for novel antibacterial agents with distinct mechanisms of action to address the impending post-antibiotic era. Antimicrobial peptides (AMPs), membrane-active peptides characterized by rapid bactericidal effects, broad-spectrum activity, and low resistance development potential, are considered promising candidates for overcoming the current multidrug resistance (MDR) crisis. However, the clinical application of AMPs is significantly limited by inherent drawbacks, including susceptibility to proteolytic degradation, poor oral bioavailability, potential mammalian cytotoxicity, low in vivo efficacy, and high production costs. These limitations have spurred extensive efforts to redesign and modify AMPs based on their physicochemical properties and mechanisms. This review first summarizes four classical models describing the initial binding and membrane disruption processes of AMPs. It then focuses on recent advancements in the chemical synthesis and modification of AMPs, as well as AMP-based drug delivery systems. In conclusion, this review provides a comprehensive perspective on the mechanisms of action, progress in novel therapeutic strategies, and prospects for the clinical translation of AMPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burn and Plastic Surgery, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, China.
- Department of Plastic, Reconstructive and Cosmetic Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China.
- Department of Orthodontics, College & Hospital of Stomatology, Guangxi Medical University, Nanning, Guangxi, China.
- Department of Plastic Aesthetic Surgery, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, Army Medical University, Chongqing, China.
- Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
Zitieren
APA
Zhou, S., Sun, Z., Liu, L., Xi, Y., Zhou, L., Yang, Z., & Zhou, J. (2026). Overcoming multidrug resistance: antimicrobial peptides as a next-generation therapeutic strategy. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1745427
Vancouver
Zhou S, Sun Z, Liu L, Xi Y, Zhou L, Yang Z, et al. Overcoming multidrug resistance: antimicrobial peptides as a next-generation therapeutic strategy. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1745427
BibTeX
@article{Zhou2026,
author = {Zhou, Shiqi and Sun, Zixuan and Liu, Luojia and Xi, Yuanyin and Zhou, Linxi and Yang, Zhibing and Zhou, Junli},
title = {Overcoming multidrug resistance: antimicrobial peptides as a next-generation therapeutic strategy},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1745427}
}
EUVIMED